Almost half of patients with COVID-19 also experience GI symptoms. The long-term consequences of COVID-19 (long-COVID syndrome) include asthenia and GI problems: diarrhea, constipation, acid reflux, and abdominal pain. New microbial-derived substances with increased safety profile – metabiotics/postbiotics - are promising in correction of GI symptoms. A new supplement containing metabiotic from Bacillus subtilis and FOS (Bactimunal®, Kraft Group Ltd, Russian Federation) is effective in patients with long-COVID syndrome reducing asthenia, GI complaints, and dysbiotic changes in GI microbiome. Our results open up new perspectives in prevention and correction of long-term COVID19 consequences.
No takes yet. Share an insight, caveat, or question.
Sinitsa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: